J9037 HCPCS Level II code: Injection, belantamab mafodotin-blmf, 0.5 mg
CMS terminated J9037: its last date of service was Mar 31, 2025. It stays here for looking up older claims; newer services need a current code.
Official description
J9037Injection, belantamab mafodotin-blmf, 0.5 mg
Short description: Inj belantamab mafodot blmf
HCPCS · United States
Medicare details
The indicators CMS publishes with J9037 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- Type of service
- Medical care
- BETOS category
- Chemotherapy
- Added
- Apr 1, 2021
- Terminated after
- Mar 31, 2025
Where J9037 sits
- 1J codesDrugs administered other than orally
- 2Terminated J9037Injection, belantamab mafodotin-blmf, 0.5 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
Is HCPCS code J9037 still valid?
No. CMS terminated J9037; its last date of service was Mar 31, 2025. It is listed for looking up services from before then. Use a current code for newer services.
Does Medicare cover J9037?
CMS lists J9037’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J9037
All J codesJ9031Bcg (intravesical) per instillationJ9032Injection, belinostat, 10 mgJ9033Injection, bendamustine hydrochloride, not otherwise specified, 1 mgJ9034Injection, bendamustine hcl (bendeka), 1 mgJ9035Injection, bevacizumab, 10 mgJ9036Injection, bendamustine hydrochloride, (belrapzo/bendamustine), 1 mgJ9038Injection, axatilimab-csfr, 0.1 mgJ9039Injection, blinatumomab, 1 microgramJ9040Injection, bleomycin sulfate, 15 unitsJ9041Injection, bortezomib, 0.1 mgJ9042Injection, brentuximab vedotin, 1 mgJ9043Injection, cabazitaxel, 1 mg